This inventor holds 1 USPTO granted patent. Top assignees: Mogam Institute for Biomedical Research, The Green Cross Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Okjae Lim: Innovator in Biomedicine
Introduction
Okjae Lim is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of biomedicine, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a key figure in the development of therapeutic antibodies.
Latest Patents
Okjae Lim holds a patent titled "Fusion Protein Comprising Anti-Mesothelin Antibody, Anti-CD3 Antibody or Anti-EGFR Antibody, Bispecific or Trispecific Antibody Comprising Same, and Uses Thereof." This patent represents a significant advancement in the creation of bispecific and trispecific antibodies, which have potential applications in targeted cancer therapies. He has 1 patent to his name, showcasing his innovative approach to solving complex medical challenges.
Career Highlights
Throughout his career, Okjae Lim has worked with prominent organizations, including the Green Cross Corporation and the Mogam Institute for Biomedical Research. His roles in these institutions have allowed him to collaborate with other experts in the field and contribute to groundbreaking research in antibody development.
Collaborations
One of his notable collaborators is Shinai Lee. Their partnership has fostered advancements in the understanding and application of therapeutic antibodies, further enhancing the impact of their work in biomedicine.
Conclusion
Okjae Lim's contributions to the field of biomedicine through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of targeted therapies, making a lasting impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile